New stem cell method may eliminate need for blood donations to maintain platelet supply

Platelets, whose primary function is to prevent bleeding, are vital for treating various forms of trauma and blood diseases. However, they can only be obtained through blood donations at present. Researchers reporting online February 13 in the Cell Press journal Cell Stem Cell recently found a way to create platelets without the need for donated blood, an advance that could possibly erase supply shortages and ensure platelet treatments for all who need them.

The supply of donated , which have a short shelf life and must be kept at room temperature, is often insufficient to meet clinical needs. In addition, while transfused platelets do not typically need to be immune-matched to patients, repeated transfusion of unmatched platelets leads to an immune reaction that eventually renders patients unresponsive to platelet .

To address these limitations, investigators from Japan developed a strategy to derive functional platelets from human induced . Induced pluripotent stem cells can be generated from various types of cells in the body, and they can in turn be coaxed to develop into nearly any other cell type. In the current study, the approach involved genetically manipulating such to become stable immortalized lines of platelet-producing cells called megakaryocyte progenitors.

The megakaryocyte progenitors could produce large quantities of platelets with clotting capabilities that were similar to those of donated platelets. Unlike freshly donated platelets, though, the immortalized megakaryocyte progenitors could be expanded and frozen for long-term storage.

"Here we established a method to achieve the long-term self-replication of megakaryocyte progenitors as an immortalized cell line, which could eventually contribute to large-scale cultivation and production of platelets," says senior author Dr. Koji Eto of Kyoto University and the University of Tokyo.

More information: Cell Stem Cell, Nakamura et al.: "Expandable megakaryocyte cell lines enable clinically-applicable generation of platelets from human induced pluripotent stem cells." dx.doi.org/10.1016/j.stem.2014.01.011

Related Stories

Method for manufacturing patient-specific human platelets

Nov 22, 2010

Skin cells from humans can be revamped into pro-clotting cells called platelets, according to a study published on November 22 in the Journal of Experimental Medicine. Patients with diseases causing thrombocytopenia—platelet defici ...

Recommended for you

Monitoring the rise and fall of the microbiome

5 hours ago

Trillions of bacteria live in each person's digestive tract. Scientists believe that some of these bacteria help digest food and stave off harmful infections, but their role in human health is not well understood.

Antioxidant biomaterial promotes healing

13 hours ago

When a foreign material like a medical device or surgical implant is put inside the human body, the body always responds. According to Northwestern University's Guillermo Ameer, most of the time, that response can be negative ...

Immune response may cause harm in brain injuries, disorders

15 hours ago

Could the body's own immune system play a role in memory impairment and cognitive dysfunction associated with conditions like chronic epilepsy, Alzheimer's dementia and concussions? Cleveland Clinic researchers believe so, ...

User comments